Record 034 · Therapeutics · 2017
50%17.34.X
Shift Bioscience
Shift Bioscience
“Cell-age reversal without the Yamanaka whole hog — safer reprogramming.”
Shift (Cambridge, UK) hunts gene sets that shift cell age with less oncogenic risk than OSKM. Partial reprogramming as a company.
Reprogramming as an engineering problem.
Pre-seed & seed. Filed from the Top Tier Impact landscape.
- Partial reprogramming
- Safety-first gene sets
Shift the age, keep the cell.
